Qing Yuan Li

Director of Finance/CFO at CytoPharm, Inc.

47 year

Health Technology

Consumer Services

Profile

Qing Yuan Li is currently the President, CFO, Director & IR Contact at CytoPharm, Inc. He previously worked as a Director at Merit Biotech, Inc. Dr. Li holds a doctorate degree from Colorado State University and an undergraduate degree from National Taiwan University.

Qing Yuan Li active positions

Companies	Position	Start
CytoPharm, Inc. CytoPharm, Inc. Pharmaceuticals: MajorHealth Technology CytoPharm, Inc. engages in the biopharmaceutical industry. The company specializes in protein drug development. It focuses on producing human natural cytokines such as interferon, interleukin and chemokine as modulators of human immune system. The products can be utilized in single or cocktail treatment model for chronic virus hepatitis, various oncology diseases, virus infection and autoimmune diseases. The company was founded on February 12, 2003 and is headquartered in Taipei, Taiwan.	Director of Finance/CFO	21/09/2011

All active positions of Qing Yuan Li

Former positions of Qing Yuan Li

Companies	Position	End
MERIT BIOTECH INC	Director/Board Member	-

See the detail of Qing Yuan Li's experience

Training of Qing Yuan Li

Colorado State University	Doctorate Degree
National Taiwan University	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Qing Yuan Li's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
MERIT BIOTECH INC	Health Technology

Private companies	1
CytoPharm, Inc. CytoPharm, Inc. Pharmaceuticals: MajorHealth Technology CytoPharm, Inc. engages in the biopharmaceutical industry. The company specializes in protein drug development. It focuses on producing human natural cytokines such as interferon, interleukin and chemokine as modulators of human immune system. The products can be utilized in single or cocktail treatment model for chronic virus hepatitis, various oncology diseases, virus infection and autoimmune diseases. The company was founded on February 12, 2003 and is headquartered in Taipei, Taiwan.	Health Technology